ArticleJournal of cancer research and clinical oncology2023

CSPG4 as a target for the specific killing of triple-negative breast cancer cells by a recombinant SNAP-tag-based antibody-auristatin F drug conjugate.

Neelakshi Mungra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.